US Patent 9255126 Chimeric alphavirus replicon particles
Patent 9255126 was granted and assigned to Novartis on February, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 10, 2009
0
Date of Patent
February 9, 2016
0
Patent Application Number
12538432
0
Patent Citations Received
Patent Inventor Names
John M. Polo
0
Zequn Tang
0
Kent Thudium
0
Silvia Perri
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9255126 Chimeric alphavirus replicon particles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
